Drugs /
hydroxychloroquine
Overview
Clinical Trials
Hydroxychloroquine has been investigated in 26 clinical trials, of which 21 are open and 5 are closed. Of the trials investigating hydroxychloroquine, 8 are phase 1 (6 open), 7 are phase 1/phase 2 (5 open), and 11 are phase 2 (10 open).
ER Positive, HER2 Deficient Expression, and HER2 Negative are the most frequent biomarker inclusion criteria for hydroxychloroquine clinical trials.
Pancreatic adenocarcinoma, breast carcinoma, and colorectal carcinoma are the most common diseases being investigated in hydroxychloroquine clinical trials [2].
Drug Details
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].
2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.